Building Viral Vector Capacity and Capabilities to Realise the Promise of Gene Therapies

Online
Live Editorial Webinar
Biologics, Bioproduction & Biologics

Information

This session was originally broadcast live on 1 November, and is now available to view on-demand.

Continuing advances in cell and gene therapy are transforming how biopharma companies treat and potentially cure certain diseases. This session will touch upon some of the opportunities, challenges, and implications for stakeholders in this fast-evolving field and provide a guide on how to Build Viral Vector Capacity and Capabilities to Realise the Promise of Gene Therapies.  

  • Challenges and opportunities of bringing viral vector products to market    
  • Importance of building capacity and capabilities to meet future needs    
  • Addressing scalability challenges